<DOC>
	<DOCNO>NCT01507337</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare exposure liraglutide young versus elderly healthy subject .</brief_summary>
	<brief_title>Comparison Effect Liraglutide Young Versus Elderly Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Good general health judge investigator , base medical history , physical examination include 12lead ECG ( electrocardiogram ) , vital sign , blood urinary laboratory assessment Age , young subject : age 1845 year ( incl . ) Age , elderly subject : age least 65 year Body Mass Index ( BMI ) 1830 kg/m^2 ( incl . ) Blood pressure , young : Diastolic 5090 mmHg , systolic 90140 mmHg Blood pressure , elderly : Diastolic 5095 mmHg , systolic 92160 mmHg History clinically significant renal , hepatic , cardiovascular , pulmonary , gastrointestinal , metabolic , endocrine , haematological , neurological , psychiatric disease , major disorder could interfere objective trial , judge investigator Impaired renal function Any clinically significant abnormal ECG ( electrocardiogram ) Active hepatitis B and/or active hepatitis C Positive HIV ( human immunodeficiency virus ) antibody Febrile illness within 5 day prior first administration liraglutide History alcoholism drug abuse last 12 month Smoking 10 cigarette per day , equivalent tobacco product Habitual excessive consumption methylxanthinecontaining beverage food ( coffee , tea , soft drink cola , chocolate ) judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>